ABOUT US
Our Mission
The mission of our company is to accelerate the drug development process by continuously inventing and deploying new artificial intelligence and cell culture technologies. We provide AI solutions to the pharma and biotechnology companies to optimize and minimize the experimental part of drugs standard safety assessment processes, as well as perform accelerated end-to-end safety assessment studies using hybrid in silico/in vitro models.
Our vision
Toxometris.ai aims to replace standard safety assessment methods with hybrid in silico/in vitro accelerated models in accordance with the requirements to appropriate toxicity endpoints. Our goal is to provide the integrated package of safety assessment solutions during the drug development process to obtain human relevant data avoiding time and cost overruns.
OUR SERVICE MODELS
AI/ML SERVICES
To help customers to optimize and minimize their experimental part of drugs standard safety assessment processes
CUSTOMIZED ASSAY SERVICE
In case if there is a need of an expert testing consultation at different stages of the drug development process our team can develop methods and protocols based on customer purposes